Decibel Therapeutics, Inc. Share-based Payment Arrangement, Expense
Decibel Therapeutics, Inc. reported Share-based Payment Arrangement, Expense of $1.37 million for the 3-month period ending 2023-06-30, per its 10-Q filed 2023-08-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2023-08-11
- Decibel Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2023-06-30 was $1.37M, a 62.29% increase year-over-year.
- Decibel Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2023-03-31 was $977.00K, a 16.03% increase year-over-year.
- Decibel Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2022-12-31 was $637.00K, a 71.70% increase year-over-year.
- Decibel Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2022-09-30 was $876.00K, a 15.44% decline year-over-year.
- Decibel Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2022 was $3.20M, a 13.60% increase from fiscal 2021.
- Decibel Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2021 was $2.82M, a 0.11% increase from fiscal 2020.
- Decibel Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2020 was $2.81M.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2023-06-30 | $1.37M 10-Q · filed 2023-08-11 | $2.35M 10-Q · filed 2023-08-11 | $2.99M derived: sum of 3 quarters · filed 2023-08-11 | $3.86M derived: sum of 4 quarters · filed 2023-08-11 |
| 2023-03-31 | $977.00K 10-Q · filed 2023-05-15 | $1.61M derived: sum of 2 quarters · filed 2023-05-15 | $2.49M derived: sum of 3 quarters · filed 2023-05-15 | $3.34M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-12-31 | $637.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $1.51M derived: sum of 2 quarters · filed 2023-03-14 | $2.36M derived: sum of 3 quarters · filed 2023-08-11 | $3.20M 10-K · filed 2023-03-14 |
| 2022-09-30 | $876.00K 10-Q · filed 2022-11-09 | $1.72M derived: sum of 2 quarters · filed 2023-08-11 | $2.56M 10-Q · filed 2022-11-09 | $2.94M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-06-30 | $846.00K 10-Q · filed 2023-08-11 | $1.69M 10-Q · filed 2023-08-11 | $2.06M derived: sum of 3 quarters · filed 2023-08-11 | $3.10M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $842.00K 10-Q · filed 2023-05-15 | $1.21M derived: sum of 2 quarters · filed 2023-05-15 | $2.25M derived: sum of 3 quarters · filed 2023-05-15 | $3.01M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $371.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $1.41M derived: sum of 2 quarters · filed 2023-03-14 | $2.17M derived: sum of 3 quarters · filed 2023-03-14 | $2.82M 10-K · filed 2023-03-14 |
| 2021-09-30 | $1.04M 10-Q · filed 2022-11-09 | $1.80M derived: sum of 2 quarters · filed 2022-11-09 | $2.45M 10-Q · filed 2022-11-09 | $4.67M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $764.00K 10-Q · filed 2022-08-10 | $1.41M 10-Q · filed 2022-08-10 | $3.63M derived: sum of 3 quarters · filed 2022-08-10 | $3.82M derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $646.00K 10-Q · filed 2022-05-12 | $2.87M derived: sum of 2 quarters · filed 2022-05-12 | $3.06M derived: sum of 3 quarters · filed 2022-05-12 | $3.23M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | $2.41M derived: sum of 2 quarters · filed 2022-03-18 | $2.59M derived: sum of 3 quarters · filed 2022-03-18 | $2.81M 10-K · filed 2022-03-18 |
| 2020-09-30 | $185.00K 10-Q · filed 2021-11-10 | $364.00K derived: sum of 2 quarters · filed 2021-11-10 | $589.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $179.00K 10-Q · filed 2021-08-10 | $404.00K 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | $225.00K 10-Q · filed 2021-05-13 |